The use of vitreous humor and pericardial fluid as alternative matrices to blood and plasma in the field of 42 forensic toxicology is described to quantitate low levels of Salvinorin A using ethion as internal standard. 43
A c c e p t e d M a n u s c r i p t 3 nausea, hearing voices, unrealistic visions, sense of death, excitement, increased heart rhythm, potential 81 self injuries without feeling pain, and, sometimes, coma, after the consumption of Salvia divinorum [7] . 82
However, no published data is available concerning reported cases of salvinorin-related deaths. 83 Nevertheless, postmortem analysis may be relevant, for instance in those cases where an individual died 84 under the influence of the drug, but whose death was not directly caused by it. 85
This drug can be taken by smoking, chewing or drinking in a tea [8] . The active ingredient, Salvinorin A, 86 has been reported to induce intense hallucinations in humans, with a typical duration of action between 87 several minutes to an hour [3] [4] [5] [6] [7] [8] [9] [10] [11] . Mouth absorption is reduced and it is also poorly absorbed in the 88 gastrointestinal tract. When smoked, the effects of salvinorin A are much more pronounced, inhaled doses 89 of 200-500 µg produce profound hallucinations [3-9, 12-13]. The complete metabolism of Salvinorin A 90 is not well known [14] . Pharmacokinetic studies showed a relatively fast elimination of Salvinorin A, with 91 a half-life (t1/2) of 75 min and a clearance (Cl/F) of 26 L/h/kg [15] . Concerning metabolism, studies 92 using rhesus monkey blood have shown that Salvinorin A is deacetylated to Salvinorin B, a compound 93 with no significant affinity to k-opioid receptors [16] [17] . 94
95
In 2005, two studies were published, in which Salvinorin A was determined in biological fluids: the first 96 one was in human plasma, urine, saliva and sweat using liquid-liquid extraction coupled with gas 97 chromatography-mass spectrometry [13] ; and the second was in human and rhesus monkey plasma, 98 human urine and in rhesus monkey cerebrospinal fluid, utilizing solid-phase extraction and high 99 performance liquid chromatography -atmospheric pressure chemical ionization mass spectrometry [10] . 100
Later, in 2008, Salvinorin A was studied in human urine and blood samples by solid-phase extraction and 101 liquid chromatography -electrospray ionization mass spectrometry [18] . Finally, in 2012 and 2013, this 102 compound was analysed in human urine using either liquid-liquid extraction or solid-phase 103 microextraction with comprehensive two -dimensional gas chromatography-time of flight mass 104 spectrometry [19] and microextraction in packed syringe with gas chromatography-mass spectrometry 105
[20]. As we can see, there are limited data and a few analytical methods available in the scientific 106 literature for the determination of this compound in biological fluids, and data related to concentrations 107 obtained in authentic samples are scarce. 108
The identification and quantitation of drugs in biological specimens is one of the most important 109 objectives in forensic toxicology because in some postmortem cases, neither blood nor urine can be 110 collected due to severe exsanguination or advanced putrefaction. In these situations vitreous humor and 111 pericardial fluid can be useful. However, these biological matrices should not be seen as substitutes for 112 blood but as complementary specimens that can provide important information about the intake of toxic 113 substances. Vitreous humor is mainly composed of water (99%) and is anatomically protected from 114 contamination and bacterial degradation due to the protected environment inside the ocular globe. A 115 disadvantage of this matrix is the limited volume that can be collected during autopsy (1-2 mL per eye) 116
[21]. Pericardial fluid, has several advantages as a matrix in forensic toxicology, such as the high volume 117 that can be collected during autopsy (about 10 mL). This specimen is easily obtained from a closed cavity Selectivity was studied by analyzing ten pools from different sources of blank samples of each matrix: 189 vitreous humor, pericardial fluid, blood and plasma. They were checked for interferences at the retention 190 times and monitored ions for the analyte of interest and the internal standard. Also, they were analysed for 191 potential interferences from other substances, namely the most commonly encountered in routine analysis 192 in our laboratory (medical substances, pesticides and drugs of abuse, Table1). From each pool, two sets of 193 samples (n=10) were prepared into 10 mL glass tubes, and they were spiked with the same concentration 194 (100 ng/mL) of all the compounds presented in Table1; in addition, ten of these samples were further 195 spiked with Salvinorin A (10 ng/mL). It was obtained ten positive and ten negative samples which were (if the relative intensity of the ion is within a 25-50 % interval of the base peak in the control sample, a 204 maximum relative tolerance of ±20 % will be allowed for the same ion in the sample; if this intensity is 205 less than 25 % or higher than 50% in the control sample, then absolute tolerances of ±5 and ±10%, 206 respectively, will be allowed for the ion in the sample). 207
In order to determine calibration curves, a linear range was established between 5 and 100 ng/mL (5,
concentrations] within a ±15 % interval, except at the LLOQ, for which ±20 % was accepted. 213
The potential for carryover was analyzed by injecting extracted blank, immediately after analysis of the 214 highest calibrator from each calibration curve. 215
The LLOQ was defined as the minimum concentration of Salvinorin A that could be measured with 216 adequate precision (coefficient of variation <20 %) and accuracy (±20 %). The LOD was defined as the 217 lowest concentration yielding a signal-to-noise ratio of at least three. The intra-day precision was 218 determined by the analysis of five QC samples at each concentration level (low, medium and high) in 219 each matrix on one day. It was characterized in terms of coefficient of variation (CV, %). The 220 intermediate precision and accuracy were assessed by the analysis of three QC samples at each 221 concentration level (low, medium and high) in each matrix on five different days. Accuracy was 222 calculated in terms of mean relative error (RE, %) between the measured and the spiked concentrations 223 for all QC samples; 15% was the limit of the acceptable variability for all concentrations. 224
The extraction efficiency was evaluated by analysis of six QC samples at each concentration level (low, 225 medium and high) in each matrix, in which the IS was added after extraction. After that, the obtained 226 peak area ratios were compared to those obtained by spiking blank extracts with the same concentrations 227 of Salvinorin A (100 % recovery). 228
To study the stability of Salvinorin A was used three QC samples at each concentration level (low, 229 medium and high). The stability of the processed samples was evaluated through analysis of the extracts 230 under the conditions of GC-MS analysis during 24h. For bench-top stability, samples of each matrix were 231 spiked and left at room temperature for 3 h, after that they were extracted and compared with freshly 232 spiked samples. To evaluate freeze/thaw cycles, the samples were spiked and stored 24 h at -15 ºC, after 233 this period, they were completely thawed and then frozen once again under the same conditions (a total of 234 three cycles was studied). Storage periods were one day, three days, and seven days, and the samples 235 were analysed after the third cycle. Comparisons between the means concentrations obtained in the by the analysis of the negative blank pools (see Figures 2 and 3 ). This indicates that neither endogenous 244 matrix constituents nor the substances in Table 1 The results of the precision and accuracy are presented in Table 3 Stability of processed samples in the autosampler was guaranteed for 24h. The study also revealed that 277
Salvinorin A is stable in each matrix for 3 h at room temperature and for the freeze/thaw experiments the 278 acceptance criteria were fulfilled as shown in Table 6 . 279
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Applicability 282
This study seems to us to be very important especially because the recent cases of people hospitalized 283 with severe psychotic disorders and with serious self-inflicted injuries that occurred during the 284 hallucinogenic episodes. On the other hand, several deaths associated with the consumption of salvia 285 divinorum, were reported in a certain area of Portugal. Despite this worrying situation is occurring, 286 unfortunately the forensic toxicological service did not have any request to analyse Salvinorin A in the 287 routine casework. However, we believe that this situation is due to lack of knowledge and information 288 about this new reality which makes forensic pathologists less prone to make the requests for the analysis 289 of these new substances, as well as to collect the studied matrices. These situations can be an obstacle in 290 the development of new methodologies, so it is important to be prepared for the requests that will be 291 made in the future. 292
Nevertheless, and even though no request to analyze the substance, the developed methodology is being 293 used routinely, in presumably intoxicated individuals with drugs of abuse. So far, fourteen blood samples 294 and three vitreous humor samples were analyzed for Salvinorin A, but none was positive. Taking into 295 account the low limits of the method, it is expected that the individuals didn't consume salvia divinorum, 296 or there was a long period between the consumption and the samples collection. 297 298
Conclusions 299
According to the low volumes of samples used, and the low limits achieved using a single quadruple mass 300 spectrometer, which is available in most laboratories, the validated methodology proved to be sensitive 301 and specific for the analysis of Salvinorin A in conventional and unconventional biological matrices. 302
Furthermore, the results obtained indicate that the procedure is suitable for application in forensic 303 toxicology laboratories for the routine analysis of Salvinorin A. The small volumes required for the 304 validated procedure are extremely useful in situations when the available volume of the sample isscarce. 305
To the best of our knowledge this is the first procedure developed for the determination of Salvinorin A in 306 vitreous humor and pericardial fluid. 307
After all, the development of the presented methodology seemed to be very timely, especially due to the 308 increase in the number of cases of intoxication with this type of substances registered in the emergencies 309 of the Portuguese hospitals. So, it is very important that the pathologists are alerted to this new reality that 310 is the consumption of these kinds of drugs, mainly by young people. We believe that this procedure, in 311 the short term will be very useful for national and international application to authentic antemortem and 312 postmortem samples. A c c e p t e d M a n u s c r i p t A c c e p t e d M a n u s c r i p t A c c e p t e d M a n u s c r i p t M a n u s c r i p t 
